Evidence map›Paper›PMID 38767959›Full record

Trial reportHealth technology assessment (Winchester, England)2024

Clinical and cost-effectiveness of pessary self-management versus clinic-based care for pelvic organ prolapse in women: the TOPSY RCT with process evaluation.

Carol Bugge, Suzanne Hagen, Andrew Elders, Helen Mason, Kirsteen Goodman, Melanie Dembinsky, Lynn Melone, Catherine Best, Sarkis Manoukian, Lucy Dwyer and 13 more

Abstract readRandomized Controlled TrialMulticenter StudyEquivalence Trial
In one paragraph

Trial report in Health technology assessment (Winchester, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Carol BuggeSchool of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.ORCID 0000-0002-4071-0803
Suzanne HagenNursing, Midwifery and Allied Health Professions (NMAHP) Research Unit, Glasgow Caledonian University, Glasgow, UK.ORCID 0000-0002-9741-9160
Andrew EldersNursing, Midwifery and Allied Health Professions (NMAHP) Research Unit, Glasgow Caledonian University, Glasgow, UK.ORCID 0000-0003-4172-4702
Helen MasonYunus Centre for Social Business and Health, Glasgow Caledonian University, Glasgow, UK.ORCID 0000-0002-9303-2794
Kirsteen GoodmanNursing, Midwifery and Allied Health Professions (NMAHP) Research Unit, Glasgow Caledonian University, Glasgow, UK.ORCID 0000-0002-6590-2748
Melanie DembinskyHealth Sciences & Sport, University of Stirling, Stirling, UK.ORCID 0000-0002-1448-5358
Lynn MeloneNursing, Midwifery and Allied Health Professions (NMAHP) Research Unit, Glasgow Caledonian University, Glasgow, UK.ORCID 0000-0003-0127-2684
Catherine BestNursing, Midwifery and Allied Health Professions (NMAHP) Research Unit, Stirling, UK.ORCID 0000-0002-3652-2498
Sarkis ManoukianYunus Centre for Social Business and Health, Glasgow Caledonian University, Glasgow, UK.ORCID 0000-0002-5057-8236
Lucy DwyerThe Warrell Unit, Saint Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.ORCID 0000-0002-0284-873X
Aethele KhundaSouth Tees Hospitals NHS Foundation Trust, James Cook University Hospital, Middlesbrough, UK.ORCID 0000-0003-4574-9675
Margaret GrahamHealth Sciences & Sport, University of Stirling, Stirling, UK.ORCID 0000-0002-5057-8236
Wael AgurSchool of Medicine, Dentistry and Nursing, NHS Ayrshire & Arran, University of Glasgow, Kilmarnock, UK.ORCID 0000-0003-4836-6581
Suzanne BreemanHealth Services Research Unit (HSRU), University of Aberdeen, Aberdeen, UK.ORCID 0000-0001-9950-7079
Jane CulverhousePatient and public representative of the TOPSY trial, UK.
Angela ForrestPatient and public representative of the TOPSY trial, UK.
Mark ForrestHealth Services Research Unit (HSRU), University of Aberdeen, Aberdeen, UK.ORCID 0000-0002-2395-8823
Karen GuerreroDepartment of Urogynaecology, NHS Greater Glasgow and Clyde, Glasgow, UK.ORCID 0000-0001-9591-059X
Christine HemmingGrampian University Hospitals NHS Trust, Aberdeen Maternity Hospital and Aberdeen Royal Infirmary, Aberdeen, UK.ORCID 0000-0003-0075-9036
Doreen McClurgNursing, Midwifery and Allied Health Professions (NMAHP) Research Unit, Glasgow Caledonian University, Glasgow, UK.ORCID 0000-0002-2872-1702
John NorrieUsher Institute of Population Health Sciences and Informatics, College of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, UK.ORCID 0000-0001-9823-9252
Ranee ThakarCroydon Health Services NHS Trust, Croydon University Hospital, Croydon, UK.ORCID 0000-0002-5279-141X
Rohna KearneyThe Warrell Unit, Saint Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.ORCID 0000-0002-1489-4397

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pelvic organ prolapse is common, causes unpleasant symptoms and negatively affects women's quality of life. In the UK, most women with pelvic organ prolapse attend clinics for pessary care. Objectives: To determine the clinical effectiveness and cost-effectiveness of vaginal pessary self-management on prolapse-specific quality of life for women with prolapse compared with clinic-based care; and to assess intervention acceptability and contextual influences on effectiveness, adherence and fidelity. Design: A multicentre, parallel-group, superiority randomised controlled trial with a mixed-methods process evaluation. Participants: Women attending UK NHS outpatient pessary services, aged ≥ 18 years, using a pessary of any type/material (except shelf, Gellhorn or Cube) for at least 2 weeks. Exclusions: women with limited manual dexterity, with cognitive deficit (prohibiting consent or self-management), pregnant or non-English-speaking. Intervention: The self-management intervention involved a 30-minute teaching appointment, an information leaflet, a 2-week follow-up telephone call and a local clinic telephone helpline number. Clinic-based care involved routine appointments determined by centres' usual practice. Allocation: Remote web-based application; minimisation was by age, pessary user type and centre. Blinding: Participants, those delivering the intervention and researchers were not blinded to group allocation. Outcomes: The patient-reported primary outcome (measured using the Pelvic Floor Impact Questionnaire-7) was prolapse-specific quality of life, and the cost-effectiveness outcome was incremental cost per quality-adjusted life-year (a specifically developed health Resource Use Questionnaire was used) at 18 months post randomisation. Secondary outcome measures included self-efficacy and complications. Process evaluation data were collected by interview, audio-recording and checklist. Analysis was by intention to treat. Results: Three hundred and forty women were randomised (self-management, Conclusions: Self-management was acceptable and cost-effective, led to fewer complications and did not improve or worsen quality of life for women with prolapse compared with clinic-based care. Future research is needed to develop a quality-of-life measure that is sensitive to the changes women desire from treatment. Study registration: This study is registered as ISRCTN62510577. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 16/82/01) and is published in full in

Indexed as

Cost-Benefit AnalysisPelvic Organ ProlapsePessariesQuality of LifeSelf-ManagementAdultAgedFemaleHumansMiddle AgedQuality-Adjusted Life YearsUnited KingdomCOST–BENEFIT ANALYSISFEMALEHEALTH CAREHEALTH RESOURCESHUMANSINFORMED CONSENTOUTCOME ASSESSMENTOUTPATIENTSPELVIC ORGAN PROLAPSEPESSARIESPROCESS EVALUATIONQUALITATIVE METHODSQUALITY-ADJUSTED LIFE-YEARSQUALITY OF LIFERANDOMISED CONTROLLED TRIALSELF-EFFICACYSELF-MANAGEMENTSTATE MEDICINE

Identifiers

PMID38767959
PMCPMC11145464

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.